For the Inventor, By the Inventor

Enter inventor name

Liang Xin

USPTO Granted Patents = 19 (Patent Applications = 2)

Average Co-Inventor Count = 12.9

ph-index = 2

Forward Citations = 18(Granted Patents)

Location History:

Xi+3 an, CN (2022 - 2023)
Xi'an, CN (2020 - 2024)

Company Filing History:

Shaanxi University of Science and Technology

Shaanxi Panlong Pharmaceutical Co., Ltd.

Xi'an Taikomed Pharmaceutical Technology Co., Ltd.

Xixian New District Fenghou Original Pharmaceutical Technology Co., Ltd.

Shaanxi Panlong Pharmaceutical Group Limited by Share Ltd.

where one patent can have more than one assignee

Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12221424 - 3-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound inhibiting coronavirus 3CL protease activity and preparation method and use thereof (2025-02-11),

2. 11872202 - Pleuromutilin cinnamic acid ester compounds with activities against antibiotic-resistant infections (2024-01-16),

3. 11712457 - seed extract composition and its application in antibiotic-resistant infections (2023-08-01),

4. 11639516 - Hydroxytyrosol sturgeon skin gelatin film with antioxidant activity anddetection ability and a method of preparing the same (2023-05-02),

5. 11612603 - 3-triazolyl methyl-1,3,5-triazine-2,4-dione compounds and preparation method and application thereof (2023-03-28),

6. 11597714 - Pleuromulin lipoic acid ester with antibacterial activity and a method of preparing the same (2023-03-07),

7. 11555016 - Pleuromulin 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ester with antibacterial activity and a method of preparing the same (2023-01-17),

8. 11530195 - Protacs targeting coronavirus 3CL protease and preparation method and application thereof (2022-12-20),

9. 11518759 - Protacs based on VHL ligand targeting coronavirus 3CL protease and preparation method and application thereof (2022-12-06),

10. 11518740 - Pleuromutilin (phenylthio)acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-12-06),

11. 11512049 - Pleuromutilin 2-[(diphenylmethyl)thio] acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),

12. 11510905 - Pleuromutilin (E)-4-(1-imidazoylmethyl)cinnamic acid ester with anti-drug resistant bacteria activity and a method of preparing the same (2022-11-29),

13. 11401233 - Pleuromutilin salicylic acid ester with antibacterial activity and a method of preparing the same (2022-08-02),

14. 11186607 - Pleuromutilin ursodeoxycholic acid ester with antibacterial activity and a method of preparing the same (2021-11-30),

15. 11168049 - Pleuromulin tretinoin ester with antibacterial activity and a method of preparing the same (2021-11-09),

Title: Inventor Liang Xin: Revolutionizing Technology in Xi'an

Introduction: Liang Xin is a visionary inventor based in Xi'an, China, known for his groundbreaking contributions to the field of technology.

Latest Patents: Liang Xin holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Liang Xin has worked with leading tech companies in China, spearheading research and development projects that have led to significant advancements in various industries.

Collaborations: Liang Xin has collaborated with top research institutions and universities in China, fostering a culture of innovation and knowledge-sharing to drive technological progress in the region.

Conclusion: Liang Xin's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists in Xi'an and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…